Schwartz Amy R, Levin Forrest L, O'Neil Joseph A, Braithwaite R Scott
Yale University School of Medicine, VA Connecticut Healthcare System, 950 Campbell Ave, 11ACSL, West Haven, CT 06516. E-mail:
Am J Manag Care. 2015 Jul 1;21(7):e439-46.
To test the feasibility of using an electronic medical record (EMR)-based decision support system (DSS) that incorporates morbidity and frailty information to individualize colorectal cancer (CRC) screening recommendations.
Our framework used the payoff time, defined as the minimum time until the benefits of screening exceed the harms.
Subjects were 24 patients eligible for CRC screening and 22 primary care providers (PCPs). Measures included PCP satisfaction with existing reminder systems and with decision support.
The run-in phase, during which the intervention was inactive but its performance was verified, had 14 patients enrolled. The intervention phase, during which payoff time and life expectancy calculations were used to recommend for or against CRC screening, had 10 patients enrolled. Of the 10 patients enrolled in the intervention phase, the DSS recommended in favor of CRC screening for 6 patients. (The PCPs also recommended it for those 6 patients, although 3 refused the screening.) The DSS recommended against CRC screening for 4 patients, while the PCPs recommended against it for 3 of those 4 and ordered the screening for 1 patient. PCPs who had patients enrolled in the intervention phase indicated interest in having payoff time information for all patients eligible for CRC screening. This pilot study was small and was not powered to determine the effect of the intervention on screening behavior.
Colorectal cancer screening involves balancing immediate harms with longer-term benefits; EMR decision support may facilitate personalized benefit/harm assessment. The payoff time framework is feasible for implementation in EMR decision support.
测试使用基于电子病历(EMR)的决策支持系统(DSS)的可行性,该系统纳入发病率和虚弱信息以个性化结直肠癌(CRC)筛查建议。
我们的框架使用了收益时间,定义为筛查益处超过危害的最短时间。
受试者为24名符合CRC筛查条件的患者和22名初级保健提供者(PCP)。测量指标包括PCP对现有提醒系统和决策支持的满意度。
预运行阶段有14名患者入组,在此阶段干预措施未启动但其性能得到验证。干预阶段有10名患者入组,在此阶段使用收益时间和预期寿命计算来推荐进行或不进行CRC筛查。在干预阶段入组的10名患者中,DSS建议6名患者进行CRC筛查(PCP也对这6名患者给出了相同建议,尽管其中3人拒绝了筛查)。DSS建议4名患者不进行CRC筛查,而PCP对这4名患者中的3人给出了相同建议,并为1名患者安排了筛查。在干预阶段有患者入组的PCP表示有兴趣获取所有符合CRC筛查条件患者的收益时间信息。这项试点研究规模较小,没有足够的能力来确定干预对筛查行为的影响。
结直肠癌筛查涉及平衡即刻危害与长期益处;EMR决策支持可能有助于个性化的利弊评估。收益时间框架在EMR决策支持中实施是可行的。